LB Pharmaceuticals (LBRX) director awarded 10,000 stock options at $27.95
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
LB Pharmaceuticals Inc. director Garland J. Scott received a grant of stock options covering 10,000 shares of common stock. The options have an exercise price of $27.95 per share and expire on June 2, 2036. This is a compensation-related award, not an open-market purchase or sale.
According to the terms, 100% of the shares underlying the option vest on the earlier of June 3, 2027 or the date of the company’s next annual meeting of stockholders, subject to Scott’s continuous service through the vesting date. Following the grant, Scott holds 10,000 stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Garland J. Scott
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 10,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 10,000 options
Exercise price: $27.95 per share
Expiration date: June 2, 2036
+3 more
6 metrics
Option grant size
10,000 options
Stock Option (Right to Buy) granted to director
Exercise price
$27.95 per share
Price to buy underlying LB Pharmaceuticals common stock
Expiration date
June 2, 2036
Options lapse if not exercised by this date
Vesting trigger date
June 3, 2027
Vests on earlier of this date or next annual meeting
Underlying shares
10,000 shares
Common stock underlying the option grant
Post-transaction derivative holdings
10,000 options
Total options held directly after this grant
Key Terms
Stock Option (Right to Buy), exercise price, vesting, annual meeting of stockholders, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 27.9500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"100% of the shares underlying the option vest on the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"the date of the Issuer's next annual meeting of stockholders"
expiration date financial
"expiration_date: 2036-06-02T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did LB PHARMACEUTICALS INC (LBRX) report for Garland J. Scott?
LB Pharmaceuticals reported that director Garland J. Scott received a grant of stock options for 10,000 shares of common stock as compensation. The award is a non-cash grant and does not represent an open-market purchase or sale of LBRX shares.
What is the exercise price of Garland J. Scott’s new LB PHARMACEUTICALS (LBRX) stock options?
The granted stock options have an exercise price of $27.95 per share. This means Scott can buy up to 10,000 LB Pharmaceuticals common shares at $27.95, once the options vest and before they expire on June 2, 2036.
When do Garland J. Scott’s LB PHARMACEUTICALS (LBRX) options vest?
All 10,000 options vest 100% on the earlier of June 3, 2027 or the date of LB Pharmaceuticals’ next annual meeting of stockholders. Vesting is subject to Scott’s continuous service with the company through the applicable vesting date.
When do the newly granted LB PHARMACEUTICALS (LBRX) stock options expire?
The stock options granted to Garland J. Scott expire on June 2, 2036. After that expiration date, any unexercised options become worthless, so they must be exercised, if at all, between vesting and this expiration date.
How many LB PHARMACEUTICALS (LBRX) stock options does Garland J. Scott hold after this grant?
After the reported transaction, Garland J. Scott holds 10,000 stock options directly. These options each relate to one share of LB Pharmaceuticals common stock and are subject to vesting and an exercise price of $27.95 per share until June 2, 2036.